MiR‐181a‐5p negatively regulates the signaling of nuclear factor κ–light‐chain enhancer of activated B cells (NF‐κB) in diffuse large B‐cell lymphoma (DLBCL). Here, NFKB1 is linked to diffuse large B-cell lymphoma.